Robert L. de Jager

Robert L. de Jager

Nessuna posizione attualmente

82 anni
Health Technology
Commercial Services
Consumer Services

Provenienza dei contatti di primo grado di Robert L. de Jager

EntitàTipo di entitàSettore Industriale
Public Company Pharmaceuticals: Major 8
Public Company Biotechnology 6
5
Subsidiary Pharmaceuticals: Major 5
4
Subsidiary Pharmaceuticals: Major 4

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Robert L. de Jager tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
The University of Chicago College/University

Helen Kim

John E. Crawford

Chris LeMasters

Masters Business Admin

Masters Business Admin

Masters Business Admin

Boston College College/University

Gregory Weaver

James Dentzer

Michael MacLean

Masters Business Admin

Undergraduate Degree

Undergraduate Degree

Pharmaceuticals: Major

Eckard Weber

John E. Crawford

Chris LeMasters

Director/Board Member

Director of Finance/CFO

Founder

The University of Chicago Booth School of Business College/University

Helen Kim

James Dentzer

Graduate Degree

Masters Business Admin

Pharmaceuticals: Major

Michael Perry

Cecil B. Pickett

General Counsel

Corporate Officer/Principal

University of California, Los Angeles College/University

Cecil B. Pickett

David Myles

Doctorate Degree

Corporate Officer/Principal

College/University

Helen Kim

John Round

Undergraduate Degree

Undergraduate Degree

IMUNON, INC. Biotechnology

Gregory Weaver

James Dentzer

Director of Finance/CFO

Director/Board Member

University of California, Berkeley College/University

Philip Gotwals

Caroline Loewy

Doctorate Degree

Undergraduate Degree

College/University

Matthew Onaitis

Caroline Loewy

Undergraduate Degree

Graduate Degree

Pharmaceuticals: Major

Eckard Weber

John E. Crawford

Chief Executive Officer

Director of Finance/CFO

RECEPTOS INC Pharmaceuticals: Major

Marcus F. Boehm

James R. Schmidt

Founder

Director of Finance/CFO

Pharmaceuticals: Major

Cecil B. Pickett

Director/Board Member

Investment Trusts/Mutual Funds

Marcus F. Boehm

Director/Board Member

Pharmaceuticals: Major

Cecil B. Pickett

Director/Board Member

Investment Banks/Brokers

Caroline Loewy

Analyst-Equity

Biotechnology

Marcus F. Boehm

Founder

CORCEPT THERAPEUTICS INCORPORATED Pharmaceuticals: Major

Caroline Loewy

Director of Finance/CFO

ZOGENIX, INC. Pharmaceuticals: Major

Caroline Loewy

Director/Board Member

Miscellaneous Commercial Services

Caroline Loewy

Director/Board Member

LIGAND PHARMACEUTICALS INCORPORATED Pharmaceuticals: Major

Marcus F. Boehm

Corporate Officer/Principal

CYMABAY THERAPEUTICS, INC. Biotechnology

Caroline Loewy

Director/Board Member

Stony Brook University College/University

Marcus F. Boehm

Doctorate Degree

University of California San Diego College/University

Marcus F. Boehm

Undergraduate Degree

Kcnq2 Cure Alliance, Inc.

Caroline Loewy

Director/Board Member

EFFECTOR THERAPEUTICS, INC. Biotechnology

Caroline Loewy

Director/Board Member

APTOSE BIOSCIENCES INC. Pharmaceuticals: Major

Caroline Loewy

Director/Board Member

PHASEBIO PHARMACEUTICALS, INC. Pharmaceuticals: Major

Caroline Loewy

Director/Board Member

ACHIEVE LIFE SCIENCES, INC. Pharmaceuticals: Major

Caroline Loewy

Founder

Miscellaneous Commercial Services

Cecil B. Pickett

Corporate Officer/Principal

Pharmaceuticals: Major

Cecil B. Pickett

Chief Tech/Sci/R&D Officer

GAMIDA CELL LTD. Pharmaceuticals: Major

Michael Perry

Director/Board Member

Investment Managers

Michael Perry

Private Equity Investor

Extropy Pharmaceuticals, Inc.

Michael Perry

Chief Executive Officer

University of Guelph College/University

Michael Perry

Doctorate Degree

Statistiche

Distribuzione geografica

Stati Uniti 47
Canada 4
Israele 2

Settori

Health Technology 27
Consumer Services 11
Finance 7
Commercial Services 4
Miscellaneous 2

Posizioni

Director/Board Member 114
Corporate Officer/Principal 63
Director of Finance/CFO 39
Independent Dir/Board Member 38
Chief Executive Officer 28
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA